Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias.

Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

1993 • 28,274 citations

Prediction of Coronary Heart Disease Using Risk Factor Categories

1998 • 9,392 citations

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1994 • 8,631 citations

The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

1996 • 7,450 citations

Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

1995 • 7,378 citations

Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction

1998 • 7,057 citations

Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels

1998 • 5,293 citations

Physical Activity and Health: A Report of the Surgeon General

1995 • 5,036 citations

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

1986 • 2,283 citations

Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B

1990 • 2,192 citations

Can lifestyle changes reverse coronary heart disease?

1990 • 2,122 citations

Prescribing Personalized Nutrition for Cardiovascular Health: Are We Ready?

2014 • 1,880 citations

Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease

1994 • 1,697 citations

Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations

1999 • 1,333 citations

Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention1European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network.1,2Published simultaneously in the European Heart Journal 1998;19:1434–1503 and the Journal of Hypertension (…

1998 • 1,292 citations

Effect of Statins on Risk of Coronary Disease

1999 • 1,257 citations

Prevention of coronary heart disease in clinical practice Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention

1998 • 1,120 citations

Effect of Partial Ileal Bypass Surgery on Mortality and Morbidity from Coronary Heart Disease in Patients with Hypercholesterolemia

1990 • 999 citations

The Effect of Aggressive Lowering of Low-Density Lipoprotein Cholesterol Levels and Low-Dose Anticoagulation on Obstructive Changes in Saphenous-Vein Coronary-Artery Bypass Grafts

1997 • 954 citations

Aggressive Lipid-Lowering Therapy Compared with Angioplasty in Stable Coronary Artery Disease

1999 • 945 citations

Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP).

1994 • 896 citations

Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience)

1992 • 895 citations

Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)

1992 • 847 citations

Lipid Research Clinics Program

1984 • 837 citations

Regression of Coronary Atherosclerosis During Treatment of Familial Hypercholesterolemia With Combined Drug Regimens

1990 • 793 citations

Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.

1984 • 685 citations

Lipoprotein Changes and Reduction in the Incidence of Major Coronary Heart Disease Events in the Scandinavian Simvastatin Survival Study (4S)

1998 • 639 citations

Hypertriglyceridemia, Atherogenic Dyslipidemia, and the Metabolic Syndrome

1998 • 538 citations

Beneficial Effects of Colestipol-Niacin on Coronary Atherosclerosis

1990 • 492 citations

Effect of weight on cardiovascular disease

1996 • 422 citations

Role of Lipoprotein(a) and Apolipoprotein(a) Phenotype in Atherogenesis

1999 • 283 citations

The Insulin Resistance—Dyslipidemic Syndrome of Visceral Obesity: Effect on Patients' Risk

1998 • 269 citations

Guide to Primary Prevention of Cardiovascular Diseases

1997 • 221 citations

Diet, lifestyle, and the etiology of coronary artery disease: the Cornell China Study

1998 • 175 citations

Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up

1990 • 119 citations

Lipoprotein(a) Interactions With Lipid and Nonlipid Risk Factors in Early Familial Coronary Artery Disease

1997 • 101 citations

The effect of meal replacements high in glycomacropeptide on weight loss and markers of cardiovascular disease risk

2008 • 80 citations

Rationale for and outline of the recommendations of the Working Group on Hypercholesterolemia and Other Dyslipidemias: interim report. Dyslipidemia Working Group of Health Canada.

1998 • 40 citations

Deleted Work

1955 • 0 citations